Aytu Biopharma (AYTU) EBIT Margin Growth (3y) (2017 - 2026)
Aytu Biopharma (AYTU) EBIT Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Aytu Biopharma | 24.75 Mn | -1.96 Mn | 7.60 Mn | 490.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 490.00 |
| Dec 31, 2025 | 1,314.00 |
| Sep 30, 2025 | -429.00 |
| Jun 30, 2025 | 1,135.00 |
| Mar 31, 2025 | 23,388.00 |
| Dec 31, 2024 | 3,839.00 |
| Sep 30, 2024 | 12,089.00 |
| Jun 30, 2024 | 8,694.00 |
| Dec 31, 2023 | 5,359.00 |
| Sep 30, 2023 | 2,144.00 |
| Jun 30, 2023 | 4,520.00 |
| Mar 31, 2023 | 2,113.00 |
| Dec 31, 2022 | 13,031.00 |
| Sep 30, 2022 | 32,235.00 |
| Jun 30, 2022 | 20,522.00 |
| Mar 31, 2022 | -3,997.00 |
| Dec 31, 2021 | 20,468.00 |
| Sep 30, 2021 | 11,217.00 |
| Jun 30, 2021 | 31,112.00 |
| Dec 31, 2020 | 34,315.00 |